Life Science News

RSS

Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development

Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company, Servier, announce the extension of a strategic collaboration to deliver industry-proven, innovative characterization and quality control workflows for the simplified analysis of complex therapeutic proteins to advance biopharmaceutical discovery and development.

From Thermo Fisher Scientific Inc. 2 Nov 2020

University of Illinois Urbana-Champaign professor wins $4.5 million for breast cancer research and therapy

University of Illinois Urbana-Champaign Professor of Molecular and Integrative Physiology Erik Nelson has won a $4.5M Era of Hope Scholar Award from the United States Department of Defense (DoD) Breast Cancer Research Program (BCRP).

30 Oct 2020

Beetroot peptide may be a good candidate for development of a drug to treat inflammatory diseases

In a recent study, a research group led by Christian Gruber at MedUni Vienna's Institute of Pharmacology isolated a peptide (small protein molecule) from beetroot.

30 Oct 2020

Researchers design a light-sensitive inhibitor that can control cell division and cell death

Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have designed a light-sensitive inhibitor that can control cell division and cell death - and provides a promising approach for studies of essential cellular processes and the development of novel tumor therapies.

30 Oct 2020

The road to achieving single molecular spectroscopy using nanoIR

In this interview, Francesco Simone Ruggeri from the University of Cambridge talks to News-Medical Life Sciences about their research into biomolecules and the methods that are helping to achieve spectra at the single-molecule scale.

From Bruker Nano Surfaces and Metrology 30 Oct 2020

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

Breast cancer is the leading cause of cancer-related death among the female population globally, despite the ever-growing technology of early detection.

From Bruker BioSpin Group 30 Oct 2020

Human immune system may play key role in shaping the microbiome composition

The gut is an unusually noisy place, where hundreds of species of bacteria live alongside whatever microbes happen to have hitched a ride in on your lunch.

30 Oct 2020

UC scientist receives research grant to explore the benefits of proprietary surfactants

University of Cincinnati cosmetic scientist Harshita Kumari has received a research grant for more than $700,000 for a multi-year study to explore certain new proprietary surfactants for industrial applications and personal care products such as skin- and haircare as well as laundry detergents.

30 Oct 2020

Moscow scientists discover and explain the activity mechanism of new anti-cancer molecule

A group of Moscow scientists has discovered and explained the activity mechanism of a new anti-cancer molecule -- diphenylisoxazole.

29 Oct 2020

Toxin-carrying virus implicated in the emergence of new Salmonella strain in pigs

Researchers at the Quadram Institute have implicated a toxin-carrying virus in the emergence of a new strain of Salmonella in pigs.

29 Oct 2020

Study reveals how gene control mechanisms define the identity of developing brainstem neurons

A recent study at the University of Helsinki reveals how gene control mechanisms define the identity of developing neurons in the brainstem.

29 Oct 2020

Tumor suppressor gene represses 'jumping genes'

About half of all tumors have mutations of the gene p53, normally responsible for warding off cancer. Now, UT Southwestern scientists have discovered a new role for p53 in its fight against tumors: preventing retrotransposons, or "jumping genes," from hopping around the human genome.

29 Oct 2020

Severe ulcerative colitis linked to a newly-discovered strain of oral bacteria

Bacteria from the mouth could hold clues to understanding – and potentially treating – severe ulcerative colitis, a painful bowel disease.

29 Oct 2020

Cell biologists and bioimaging expert team up to solve fourth dimension secrets

Cell biologists at the University of Illinois at Urbana-Champaign and Bar-Ilan University at Israel and a bioimaging expert at the University of Central Florida are teaming up in what they hope may lead to a major breakthrough in understanding of the three-dimensional organization of the nucleus over time and their role in certain diseases.

29 Oct 2020

Study reveals complex and vast diversity of African genetic variation

The study, in which six Wits researchers were involved, show that these newly discovered variants were found mostly among newly sampled ethnolinguistic groups.

29 Oct 2020

Deep learning models help hunt for COVID-19 drugs

Michigan State University Foundation Professor Guowei Wei wasn't preparing machine learning techniques for a global health crisis. Still, when one broke out, he and his team were ready to help.

28 Oct 2020

Penn researchers awarded $5.4 million to find genetic risk markers for testicular cancer

The international hunt to find more genetic risk markers for testicular cancer is expanding. A team of researchers led by Katherine L. Nathanson, MD, deputy director of the Abramson Cancer Center and the Pearl Basser Professor for BRCA-Related Research in the Perelman School of Medicine at the University of Pennsylvania, was recently awarded $5.4 million over five years from the National Institutes of Health to continue the long-standing genomics work of the TEsticular CAncer Consortium (TECAC).

28 Oct 2020

CN Bio announces launch of drug metabolism and safety toxicity testing services

CN Bio, a leading 3D cell culture company, that has developed single and multi-organ microphysiological systems to improve the accuracy and efficiency of drug discovery, today announced the commercial launch of its Drug Metabolism and Safety Toxicity Testing Services.

28 Oct 2020

Uniqsis' FlowSyn Multi-X takes the drudgery out of reaction optimization

The FlowSyn Multi-X from Uniqsis takes the drudgery out of reaction optimization - effortlessly converting your batch chemistry methods to more efficient, higher yielding flow chemistry protocols.

From Uniqsis Ltd 28 Oct 2020

Stewart Kay joins Adaptate Biotherapeutics as Chief Business Officer

Adaptate Biotherapeutics, a company focused on developing antibody-based therapeutics for modulation of gamma delta T cells, today announced the appointment of Stewart Kay as Chief Business Officer.

28 Oct 2020

Life Science News

Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development

University of Illinois Urbana-Champaign professor wins $4.5 million for breast cancer research and therapy

Beetroot peptide may be a good candidate for development of a drug to treat inflammatory diseases

Researchers design a light-sensitive inhibitor that can control cell division and cell death

The road to achieving single molecular spectroscopy using nanoIR

High Throughput Identification and Quantification of Breast Cancer With NMR-Based Metabolomics

Human immune system may play key role in shaping the microbiome composition

UC scientist receives research grant to explore the benefits of proprietary surfactants

Moscow scientists discover and explain the activity mechanism of new anti-cancer molecule

Toxin-carrying virus implicated in the emergence of new Salmonella strain in pigs

Study reveals how gene control mechanisms define the identity of developing brainstem neurons

Tumor suppressor gene represses 'jumping genes'

Severe ulcerative colitis linked to a newly-discovered strain of oral bacteria

Cell biologists and bioimaging expert team up to solve fourth dimension secrets

Study reveals complex and vast diversity of African genetic variation

Deep learning models help hunt for COVID-19 drugs

Penn researchers awarded $5.4 million to find genetic risk markers for testicular cancer

CN Bio announces launch of drug metabolism and safety toxicity testing services

Uniqsis' FlowSyn Multi-X takes the drudgery out of reaction optimization

Stewart Kay joins Adaptate Biotherapeutics as Chief Business Officer

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest Life Science News